C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
167/37, 530/15.0
C12P 21/08 (2006.01) C07H 21/00 (2006.01) C07K 14/47 (2006.01) C07K 14/62 (2006.01) C07K 14/705 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01) C07K 16/42 (2006.01) C12N 5/12 (2006.01) C12Q 1/68 (2006.01) G01N 33/577 (2006.01)
Patent
CA 2020544
ABSTRACT MONOCLONAL ANTIBODIES INVOLVED IN ALZHEIMER'S DISEASE HYBRIDOMAS SECRETING THESE MONOCLONAL ANTIBODIES, ANTIGEN RECOGNIZED BY THESE ANTIBODIES, AND THEIR APPLICATION The invention relates to a monoclonal antibody characterized by the combination of the following properties : - it forms an immunological complex with a non- phosphorylated structural epitope of an antigen released from a sonicated NFT preparation, which itself is isolated from the cerebral cortex obtained from a patient having Alzheimer's disease, - it does not form an immunologically complex with the following proteins or peptides : . neurofilament proteins . tau protein . MAP 2 protein . ubiquitin . 4-amyloid peptide, said monoclonal antibody can be used for the diagnosis in vitro of brain diseases involving neurofibrillary degeneration.
Gheuens Jan
Van Heuverswyn Hugo
Fetherstonhaugh & Co.
Gheuens Jan
N.v. Innogenetics S.a.
Van Heuverswyn Hugo
LandOfFree
Monoclonal antibodies involved in alzheimer's disease,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies involved in alzheimer's disease,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies involved in alzheimer's disease,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1464860